Association of HIV transmission categories with sociodemographic, viroimmunological and clinical parameters of HIV-infected patients
Open Access
- 27 November 2009
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 138 (7) , 1016-1024
Abstract
SUMMARY: To analyse sociodemographic, viroimmunological and clinical parameters in different HIV-transmission categories at baseline and during treatment, 3039 patients were followed up for 12 months after the initiation of a nelfinavir-based regimen. Multiple baseline parameters were significantly different in the diverse categories, including CD4 counts (PP=0·02). There were differences in the groups regarding the CD4 response (P=0·01), but not the virological response (P=0·4), to therapy over time. Multivariate analyses revealed that transmission categories were significantly related to baseline CD4 counts (P=0·01), viral load at 12 months (P=0·0006), poorer adherence to therapy of injecting drug users (IDUs)vs. each of the other groups (Pvs. heterosexual (P=0·003) and men who have sex with men (MSM) groups (P=0·02). We conclude that transmission categories had a significant influence on several baseline parameters and viroimmunological outcomes following highly active antiretroviral therapy (HAART), as well as on adherence to therapy and to medical appointments.Keywords
This publication has 29 references indexed in Scilit:
- Predictors identified for losses to follow-up among HIV-seropositive patientsJournal of Clinical Epidemiology, 2006
- Role of Hepatitis C Virus (HCV) Viremia and HCV Genotype in the Immune Recovery from Highly Active Antiretroviral Therapy in a Cohort of Antiretroviral-Naive HIV-Infected IndividualsClinical Infectious Diseases, 2005
- Sex differences in HIV: Natural history, pharmacokinetics, and drug toxicityCurrent Infectious Disease Reports, 2005
- Hepatitis C Virus Coinfection Increases Mortality in HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era: Data from the HIV Atlanta VA Cohort StudyClinical Infectious Diseases, 2004
- Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- Greater Effect of Highly Active Antiretroviral Therapy on Survival in People Aged ⩾50 Years Compared with Younger People in an Urban Observational CohortClinical Infectious Diseases, 2003
- Coinfection With Hepatitis Viruses and Outcome of Initial Antiretroviral Regimens in Previously Naive HIV-Infected SubjectsArchives of internal medicine (1960), 2002
- The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus–Infected Persons in Clinical TrialsClinical Infectious Diseases, 2002
- Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyThe Lancet, 2000
- Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndromeJournal of Clinical Epidemiology, 1996